English

Eligibility Rheumatoid Arthritis NCT01270087

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of rheumatoid arthritis
Description

Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1]
C0003873
fulfillment of the american college of rheumatology 1987 criteria for rheumatoid arthritis
Description

Rheumatoid Arthritis Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
active disease despite treatment with at least one disease modifying anti-rheumatic drug
Description

Disease-Modifying Antirheumatic Drugs Quantity | Persistent Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0242708
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C2983415
treatment with adalimumab indicated according to the the patient's rheumatologist
Description

Indication adalimumab

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1122087
at least six swollen joints in 28-joint index
Description

Swollen joint Quantity Disease activity score using 28 joint count

Data type

boolean

Alias
UMLS CUI [1,1]
C0152031
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C2711347
crp > 8 mg / l within the last three months
Description

C-reactive protein measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201657
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with anti-tnf drugs in the last three months
Description

Anti-tumor necrosis factor alpha drug

Data type

boolean

Alias
UMLS CUI [1]
C1562242
treatment with intravenous corticosteroids within fourteen days
Description

Adrenal Cortex Hormones Intravenous

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1522726
ongoing treatment with oral high-dose corticosteroids (equivalent to ≥ 20 mg of prednisolon daily) or completed such treatment less than fifteen days before inclusion
Description

Adrenal Cortex Hormones Oral High dose | Prednisolone U/day equivalent | Adrenal Cortex Hormones Oral High dose Treatment completed

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0444956
UMLS CUI [2,1]
C0032950
UMLS CUI [2,2]
C0456683
UMLS CUI [2,3]
C3242703
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0444956
UMLS CUI [3,4]
C0580352
severe bleeding disorder
Description

Blood Coagulation Disorder Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0005779
UMLS CUI [1,2]
C0205082
extensive or refractory leg ulcers
Description

Leg Ulcer Extensive | Leg Ulcer refractory

Data type

boolean

Alias
UMLS CUI [1,1]
C0023223
UMLS CUI [1,2]
C0205231
UMLS CUI [2,1]
C0023223
UMLS CUI [2,2]
C0205269
severe peripheral vascular disease
Description

Peripheral Vascular Disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0085096
UMLS CUI [1,2]
C0205082
Back to the top of the page

Similar models

Eligibility Rheumatoid Arthritis NCT01270087

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis
Item
clinical diagnosis of rheumatoid arthritis
boolean
C0003873 (UMLS CUI [1])
Rheumatoid Arthritis Criteria Fulfill
Item
fulfillment of the american college of rheumatology 1987 criteria for rheumatoid arthritis
boolean
C0003873 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Disease-Modifying Antirheumatic Drugs Quantity | Persistent Disease
Item
active disease despite treatment with at least one disease modifying anti-rheumatic drug
boolean
C0242708 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C2983415 (UMLS CUI [2])
Indication adalimumab
Item
treatment with adalimumab indicated according to the the patient's rheumatologist
boolean
C3146298 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
Swollen joint Quantity Disease activity score using 28 joint count
Item
at least six swollen joints in 28-joint index
boolean
C0152031 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C2711347 (UMLS CUI [1,3])
C-reactive protein measurement
Item
crp > 8 mg / l within the last three months
boolean
C0201657 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Anti-tumor necrosis factor alpha drug
Item
treatment with anti-tnf drugs in the last three months
boolean
C1562242 (UMLS CUI [1])
Adrenal Cortex Hormones Intravenous
Item
treatment with intravenous corticosteroids within fourteen days
boolean
C0001617 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
Adrenal Cortex Hormones Oral High dose | Prednisolone U/day equivalent | Adrenal Cortex Hormones Oral High dose Treatment completed
Item
ongoing treatment with oral high-dose corticosteroids (equivalent to ≥ 20 mg of prednisolon daily) or completed such treatment less than fifteen days before inclusion
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C0032950 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C3242703 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0444956 (UMLS CUI [3,3])
C0580352 (UMLS CUI [3,4])
Blood Coagulation Disorder Severe
Item
severe bleeding disorder
boolean
C0005779 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Leg Ulcer Extensive | Leg Ulcer refractory
Item
extensive or refractory leg ulcers
boolean
C0023223 (UMLS CUI [1,1])
C0205231 (UMLS CUI [1,2])
C0023223 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Peripheral Vascular Disease Severe
Item
severe peripheral vascular disease
boolean
C0085096 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Back to the top of the page